Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Clinical Effectiveness of Regdanvimab Treatment for Mild-to-Moderate COVID-19: A Retrospective Cohort Study

Published:2022 Issue: Volume:96 Page:100675
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Jang Young Rock,Oh Yoon Ju,Kim Jin Yong^ORCID

Funder

Celltrion

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. World Health Organization. WHO coronavirus disease (COVID-19) dashboard; 2021. Available from: https://covid19.who.int/. Accessed November 15, 2021.

2. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment;Wouters;Lancet,2021

3. Where are we with drug treatments for covid-19?;Baraniuk;BMJ,2021

4. Repurposing drugs for treatment of COVID-19;Venkatesan;Lancet Respir Med,2021

5. Monoclonal antibodies for emerging infectious diseases - borrowing from history;Marston;N Engl J Med,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis;Kidney Research and Clinical Practice;2024-01-31

2. Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea;Infectious Diseases and Therapy;2023-10

3. Efficacy and safety of regdanvimab in patients with mild to moderate COVID‐19: A rapid review and meta‐analysis;British Journal of Clinical Pharmacology;2023-02-09

4. CLINICAL EFFECTIVENESS OF REGDANVIMAB IN THE TREATMENT OF PATIENTS WITH COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS;Studies in Medical Sciences;2023-02-01

5. Effectiveness of Regdanvimab and Remdesivir in Patients with COVID-19 at a Single Hospital;Korean Journal of Family Practice;2022-12-20